Respiratory Syncytial Virus Fusion Protein antibody | 0651
RSV encodes three envelope glycoproteins, a small hydrophobic (SH) protein of unknown function, a glycoprotein (G) known as the attachment protein, and a fusion (F) protein. The F protein directs fusion of viral and cellular membranes, resulting in viral penetration, and can lead to the formation of syncytia.
The F protein is thought to be the principal antigen responsible for inducing an immune response.
- Target Species
- Product Form
- Purified IgG - liquid
- Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
0.09% Sodium Azide (NaN3)
- Fusion protein of the human Respiratory Synctial Virus.
- Approx. Protein Concentrations
- IgG concentration 0.1mg/ml
- Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- 12 months from date of despatch
- For research purposes only
Applications of Respiratory Syncytial Virus Fusion Protein antibody
|Application Name||Verified||Min Dilution||Max Dilution|
Secondary Antibodies Available
Product Specific References
References for Respiratory Syncytial Virus Fusion Protein antibody
Schlender, J. et al. (2003) Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection.
J Virol. 77 (8): 4609-16.
Kim, Y.K. et al. (2007) Genetic variability of the fusion protein and circulation patterns of genotypes of the respiratory syncytial virus.
J Med Virol. 79 (6): 820-8.
Cianci, C. et al. (2005) Antiviral activity and molecular mechanism of an orally active respiratory syncytial virus fusion inhibitor.
J Antimicrob Chemother. 55 (3): 289-92.